Particle.news

Download on the App Store

Abdominal Fat Identified as Major Independent Risk Factor for Psoriasis

Recent research indicates GLP-1 receptor agonists may curb inflammation from abdominal obesity, offering a new treatment pathway for psoriasis.

Image
Image
Image

Overview

  • A UK Biobank analysis of over 330,000 participants, including more than 9,000 with psoriasis, found waist-to-hip ratio to be the strongest predictor of disease risk regardless of genetic factors.
  • Study authors recommend incorporating waist circumference measurements and proactive weight-management strategies into psoriasis risk assessment and care.
  • Abdominal adipose tissue is believed to promote psoriasis through inflammatory cytokines and disrupted hormone signals, prompting deeper investigation into underlying mechanisms.
  • Dermatology experts are calling for large-scale clinical trials of GLP-1 receptor agonists—currently used for diabetes and obesity—to evaluate their impact on psoriatic inflammation.
  • The findings highlight the interplay between central obesity, chronic inflammation and skin health, guiding future personalized prevention and treatment approaches.